Volunteers wanted for Covid-19 trials

personal protective equipment.

Volunteers are told there are “no direct benefits of taking part” which means they will not be paid, but are told they will be helping gain knowledge to help develop a vaccine against Covid-19.

A spokesperson for the study said: “This study will enable us to assess if healthy people can be protected from Covid-19 with this new vaccine called Chadox1 ncov-19.

“It will also give us valuable information on safety aspects of the vaccine and its ability to generate good immune responses against the virus.

“We will do this by randomly allocating participants to receive the Chadox1 ncov-19 vaccine or a Men ACWY vaccine in addition to doing blood tests, nasal and throat swabs and collecting information about Covid-19 related symptoms any other symptoms that occur after vaccination.

“Volunteers will be what group they are in.”

The clinical trial is being conducted in collaboration with multiple study sites across the UK. Those taking part in Hull will do so at sites run by the Hull University Teaching Hospitals Trust.

There are currently no licensed vaccines or specific treatments for Covid-19. Researchers say vaccines are the most cost effective way of controlling outbreaks and the international community have stepped-up their efforts towards developing one against Covid-19.

The vaccine Chadox1 ncov19 was first given to 500 healthy adults in Oxford in April as part of a separate safety trial (COV001).

Including in this current trial (COV002), the vaccine has now been given to approximately 2,000 people in total with no unexpected safety concerns to date. blinded to

Volunteers in groups one, two, seven and eight will have nine to 12 visits over a period of 12 months, depending on the dose schedule.

Group four and six volunteers,including those from Hull, will attend six visits over a period of 12 months. Group five volunteers will attend nine visits over a period of 12 months.

Adults who are aged 18 to 55 years are able to take part in group four, five or six.

To take part, you must be 18 years or over, be in good health and be based in the HU postcode area.

You must not have tested positive for Covid-19, be pregnant, intending to become pregnant, or breastfeeding during the study, have previously taken part in a trial with an adenoviral vaccine or received any other coronavirus vaccines.